Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gelderblom

Showing results (161-170 of 251) with videos related to

Pageof 26
Sort By:
Sarcoma|July 11, 2022
Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology PerspectiveK van Langevelde, A H G Cleven, A Navas Cañete, et al.
Scientific Reports|July 31, 2019
Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgeryS E Bosma, C Lancia, A J Rueten-Budde, et al.
Breast Cancer Research and Treatment|April 17, 2023
Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancerE T D Souwer, A Sanchez-Spitman, D J A R Moes, et al.
Cancer Chemotherapy and Pharmacology|October 24, 2013
Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancerD de Wit, H Gelderblom, A Sparreboom, et al.
ESMO Open|August 25, 2023
Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategiesJ-Y Blay, M von Mehren, R L Jones, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2012
Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinibR Tielen, C Verhoef, F van Coevorden, et al.
British Journal of Cancer|August 8, 2013
Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cellsJ G van Oosterwijk, M A J H van Ruler, I H Briaire-de Bruijn, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2012
The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levelsF L Opdam, V O Dezentje, J den Hartigh, et al.
Clinical Pharmacology and Therapeutics|January 10, 2008
Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: incorporating cytochrome P4503A activity measurementsA C Hooker, A J Ten Tije, M A Carducci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistanceJ G van Oosterwijk, B Herpers, D Meijer, et al.
Pageof 26

Showing results (161-170 of 251) with videos related to

Sort By:
Pageof 26
Sarcoma|July 11, 2022
Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology PerspectiveK van Langevelde, A H G Cleven, A Navas Cañete, et al.
Scientific Reports|July 31, 2019
Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgeryS E Bosma, C Lancia, A J Rueten-Budde, et al.
Breast Cancer Research and Treatment|April 17, 2023
Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancerE T D Souwer, A Sanchez-Spitman, D J A R Moes, et al.
Cancer Chemotherapy and Pharmacology|October 24, 2013
Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancerD de Wit, H Gelderblom, A Sparreboom, et al.
ESMO Open|August 25, 2023
Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategiesJ-Y Blay, M von Mehren, R L Jones, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2012
Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinibR Tielen, C Verhoef, F van Coevorden, et al.
British Journal of Cancer|August 8, 2013
Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cellsJ G van Oosterwijk, M A J H van Ruler, I H Briaire-de Bruijn, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2012
The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levelsF L Opdam, V O Dezentje, J den Hartigh, et al.
Clinical Pharmacology and Therapeutics|January 10, 2008
Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: incorporating cytochrome P4503A activity measurementsA C Hooker, A J Ten Tije, M A Carducci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistanceJ G van Oosterwijk, B Herpers, D Meijer, et al.
Pageof 26